Parallel, randomized, double-blind, placebo-controlled trial in adults for the sublingual-oral immunotherapy (SLIT) of allergic rhinoconjunctivitis with or without asthma caused by ragweed pollen

Trial Profile

Parallel, randomized, double-blind, placebo-controlled trial in adults for the sublingual-oral immunotherapy (SLIT) of allergic rhinoconjunctivitis with or without asthma caused by ragweed pollen

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jan 2015

At a glance

  • Drugs Ragweed allergy immunotherapy (Primary)
  • Indications Rhinoconjunctivitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Greer Laboratories
  • Most Recent Events

    • 06 Jan 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 27 Jun 2008 Enrolment completed according to Greer media release.
    • 27 Jun 2008 Status changed from recuiting to in progress according to Greer media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top